Febuxostat and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Febuxostat (febuxostat), especially for people who are female, 40-49 old, also take Enbrel, and have Adenomatous polyposis coli.

The phase IV clinical study analyzes which people have Uveitis when taking Febuxostat. It is created by eHealthMe based on reports of 9,653 people who have side effects when taking Febuxostat from the FDA, and is updated regularly.

What is Febuxostat?

Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 9,693 Febuxostat users. Check the latest studies of Febuxostat.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 830 drugs and 1,533 conditions by eHealthMe. Check the latest studies of Uveitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

9,653 people reported to have side effects when taking Febuxostat.
Among them, 24 people (0.25%) have Uveitis.

Among these 24 people:

What is the gender of people who have Uveitis when taking Febuxostat? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Uveitis when taking Febuxostat? *

What are other drugs people take besides Febuxostat? *

Gravol: 17 people, 70.83%
Naproxen: 17 people, 70.83%
Ibuprofen: 17 people, 70.83%
Hydroxychloroquine Sulfate: 17 people, 70.83%
Humira: 17 people, 70.83%
Xeljanz: 17 people, 70.83%
Fosamax: 17 people, 70.83%
Folic Acid: 17 people, 70.83%
Erelzi: 17 people, 70.83%
Enbrel: 17 people, 70.83%

What are other side effects people have besides Uveitis? *

Drug Ineffective: 19 people, 79.17%
Skin Ulcer: 17 people, 70.83%
Gastric Ulcer (stomach ulcer): 17 people, 70.83%
Joint Pain: 17 people, 70.83%
Rash Pruritic (redness with itching): 17 people, 70.83%
Red Blood Cell Sedimentation Rate Increased: 17 people, 70.83%
Rheumatoid Lung (blockage of the small airways of the lung associated with rheumatoid arthritis): 17 people, 70.83%
Skin Necrosis (skin damage): 17 people, 70.83%
White Blood Cell Count Decreased: 17 people, 70.83%
Synovitis (inflammation of the synovial membrane): 17 people, 70.83%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 70.83%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 17 people, 70.83%
Psoriasis (immune-mediated disease that affects the skin): 17 people, 70.83%
Adenomatous Polyposis Coli ((fap) is an inherited condition in which numerous polyps form mainly in the epithelium of the large intestine): 17 people, 70.83%
Endocarditis (inflammation in heart muscle): 4 people, 16.67%
Spondyloarthropathy (any joint disease of the vertebral column): 2 people, 8.33%
Rashes (redness): 2 people, 8.33%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 1 person, 4.17%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 4.17%
Fungal Infection: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Febuxostat and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Febuxostat:

Febuxostat (9,693 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Febuxostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (830 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,533 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on febuxostat (the active ingredients of Febuxostat) and Febuxostat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.